Table of Contents

company-logo

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

BioCorRx Dividend Announcement

• BioCorRx does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on BioCorRx dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

BioCorRx Dividend History

BioCorRx Dividend Yield

BioCorRx current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing BioCorRx stock? Use our calculator to estimate your expected dividend yield:

BioCorRx Financial Ratios

P/E ratio-0.69
PEG ratio0.21
P/B ratio-0.27
ROE42.16%
Payout ratio0.00%
Current ratio0.02
Quick ratio0.02
Cash Ratio0.00

BioCorRx Dividend FAQ

Does BioCorRx stock pay dividends?
BioCorRx does not currently pay dividends to its shareholders.
Has BioCorRx ever paid a dividend?
No, BioCorRx has no a history of paying dividends to its shareholders. BioCorRx is not known for its dividend payments.
Why doesn't BioCorRx pay dividends?
There are several potential reasons why BioCorRx would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will BioCorRx ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While BioCorRx has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is BioCorRx a dividend aristocrat?
BioCorRx is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is BioCorRx a dividend king?
BioCorRx is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is BioCorRx a dividend stock?
No, BioCorRx is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy BioCorRx stocks?
To buy BioCorRx you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy BioCorRx stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.